The company’s website currently claims that its “initially clinical trial is open to recruitment” for people with restricted or no use of both equally hands due to a cervical spinal wire harm or to amyotrophic lateral sclerosis, a neurological disorder that affects nerve cells.In the post on its website today, Neuralink states which the First